Discover 921 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 921
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
for
Neurotrophic Keratopathy
Location: Portland OR, Seatle WA, Medford OR, Loma Linda CA,
Sponsor: ReGenTree, LLC
Sex: All
Age: 18+
Code: NCT05555589
Phase3, Recruiting
Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
for
Stargardt Disease, Cone Rod Dystrophy,
Location: Portland OR, San Francisco CA, Dallas TX, Houston TX,
Sponsor: Ascidian Therapeutics, Inc
Sex: All
Age: 12+
Code: NCT06467344
Phase1, Phase2, Recruiting
Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age
for
Amblyopia
Location: Portland OR, Albany OR, Spokane WA, Sacramento CA,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 8 - 12
Code: NCT06524882
Phase3, Recruiting
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
for
Stargardt Disease, Stargardt Macular Dystrophy,
Location: Portland OR, Sacramento CA, Palo Alto CA,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 6+
Code: NCT07425574
Recruiting
A RCT of Spectacles With Aspherical Lenslets or 0.05% Atropine for Myopia Control
for
Myopia
Location: Portland OR, Palo Alto CA, Salt Lake City UT,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 5 - 11
Code: NCT07095894
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Quantification & Classification of Inflammatory Cells in Uveitis Using OCT
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Portland OR, Seattle WA, Boise ID, Salt Lake City UT,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07063745
Phase2, Phase3, Recruiting
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
for
Cutaneous Melanoma, Stage II
Location: Portland OR, Clackamas OR, Kelowna, Vallejo CA,
Sponsor: Melanoma and Skin Cancer Trials Limited
Sex: All
Age: 18+
Code: NCT03860883
Recruiting
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
for
Diffuse Large B-Cell Lymphoma
Location: Portland OR, Olympia WA, Reno NV, San Francisco CA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06717347
Phase3, Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics